6533b7d1fe1ef96bd125d501
RESEARCH PRODUCT
Patient Reported Outcome in metastatic breast cancer and platinum-resistant recurrent ovarian cancer treated with metronomic cyclophosphamide ± methotrexate: PROmetronomic - FoR.UM 19-02193
V LinzSlavomir KrajnakKatrin AlmstedtK AnicR SchwabMartina SchmidtAnne-sophie HeimesAnnette HasenburgMarco Johannes Battistasubject
Oncologymedicine.medical_specialtybusiness.industrymedicine.diseaseMetastatic breast cancerRecurrent Ovarian CancerInternal medicineMedicinePatient-reported outcomeMethotrexatebusinessMetronomic cyclophosphamidePlatinum resistantmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2021-06-01 | Senologie - Zeitschrift für Mammadiagnostik und -therapie |